Wnt inhibition induces persistent increases in intrinsic stiffness of human trabecular meshwork cells

Experimental Eye Research

Volumn 132, Issue , 2015, Pages 174-178

  Morgan, Joshua T ^a   Raghunathan, Vijay Krishna ^a   Chang, Yow Ren ^a   Murphy, Christopher J ^a,b   Russell, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atomic force microscopy; Cell stiffness; Human trabecular meshwork; Secreted frizzled related protein; Wnt

Indexed keywords

BETA CATENIN; KY 02111; LGK 974; PROTEIN INHIBITOR; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN; MEMBRANE PROTEIN; SFRP1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BASAL CELL; CELL PROLIFERATION; CELL STIFFNESS; CELLS BY BODY ANATOMY; CELLULAR PARAMETERS; CONTROLLED STUDY; FEEDBACK SYSTEM; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN TRABECULAR MESHWORK CELL; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRABECULAR MESHWORK; WNT SIGNALING PATHWAY; CELL CULTURE; DRUG EFFECTS; ELASTICITY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; YOUNG MODULUS;

BETA CATENIN; CELLS, CULTURED; ELASTIC MODULUS; ELASTICITY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROSCOPY, ATOMIC FORCE; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84922344499     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.01.025     Document Type: Article

References (43)

1. Ahearne M., Yang Y., El Haj A.J., Then K.Y., Liu K.K. Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications. J.R. Soc. Interface/the R. Soc. 2005, 2:455-463.
2. Alvarado J., Murphy C., Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984, 91:564-579.
3. Anseth K.S., Bowman C.N., Brannon-Peppas L. Mechanical properties of hydrogels and their experimental determination. Biomaterials 1996, 17:1647-1657.
4. Baleriola J., Garcia-Feijoo J., Martinez-de-la-Casa J.M., Fernandez-Cruz A., de la Rosa E.J., Fernandez-Durango R. Apoptosis in the trabecular meshwork of glaucomatous patients. Mol. Vis. 2008, 14:1513-1516.
5. Bodine P.V., Billiard J., Moran R.A., Ponce-de-Leon H., McLarney S., Mangine A., Scrimo M.J., Bhat R.A., Stauffer B., Green J., Stein G.S., Lian J.B., Komm B.S. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J.Cell. Biochem. 2005, 96:1212-1230.
6. Clark A.F., Miggans S.T., Wilson K., Browder S., McCartney M.D. Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J.Glaucoma 1995, 4:183-188.
7. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
8. Dimitriadis E.K., Horkay F., Maresca J., Kachar B., Chadwick R.S. Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys. J. 2002, 82:2798-2810.
9. Elzi D.J., Song M., Hakala K., Weintraub S.T., Shiio Y. Wnt antagonist SFRP1 functions as a secreted mediator of senescence. Mol. Cell. Biol. 2012, 32:4388-4399.
10. Freese J.L., Pino D., Pleasure S.J. Wnt signaling in development and disease. Neurobiol. Dis. 2010, 38:148-153.
11. Fuchshofer R., Tamm E.R. The role of TGF-beta in the pathogenesis of primary open-angle glaucoma. Cell. Tissue Res. 2012, 347:279-290.
12. Gess B., Halfter H., Kleffner I., Monje P., Athauda G., Wood P.M., Young P., Wanner I.B. Inhibition of N-cadherin and beta-catenin function reduces axon-induced Schwann cell proliferation. J.Neurosci. Res. 2008, 86:797-812.
13. Gottanka J., Johnson D.H., Martus P., Lutjen-Drecoll E. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J.Glaucoma 1997, 6:123-132.
14. Hoare M.J., Grierson I., Brotchie D., Pollock N., Cracknell K., Clark A.F. Cross-linked actin networks (CLANs) in the trabecular meshwork of the normal and glaucomatous human eye in situ. Invest Ophthalmol. Vis. Sci. 2009, 50:1255-1263.
15. Johnson M. What controls aqueous humour outflow resistance?. Exp. Eye Res. 2006, 82:545-557.
16. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J.Cell. Sci. 2003, 116:2627-2634.
17. Last J.A., Pan T., Ding Y., Reilly C.M., Keller K., Acott T.S., Fautsch M.P., Murphy C.J., Russell P. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol. Vis. Sci. 2011, 52:2147-2152.
18. Liton P.B., Challa P., Stinnett S., Luna C., Epstein D.L., Gonzalez P. Cellular senescence in the glaucomatous outflow pathway. Exp. Gerontol. 2005, 40:745-748.
19. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
20. Liu J., Pan S., Hsieh M.H., Ng N., Sun F., Wang T., Kasibhatla S., Schuller A.G., Li A.G., Cheng D., Li J., Tompkins C., Pferdekamper A., Steffy A., Cheng J., Kowal C., Phung V., Guo G., Wang Y., Graham M.P., Flynn S., Brenner J.C., Li C., Villarroel M.C., Schultz P.G., Wu X., McNamara P., Sellers W.R., Petruzzelli L., Boral A.L., Seidel H.M., McLaughlin M.E., Che J., Carey T.E., Vanasse G., Harris J.L. Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:20224-20229.
21. Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp. Eye Res. 2005, 81:1-4.
22. Macdonald B.T., He X. Frizzled and LRP5/6 receptors for Wnt/beta-catenin signaling. Cold Spring Harb. Perspect. Biol. 2012, 4.
23. Mahaffy R.E., Shih C.K., MacKintosh F.C., Kas J. Scanning probe-based frequency-dependent microrheology of polymer gels and biological cells. Phys. Rev. Lett. 2000, 85:880-883.
24. Maher M.T., Flozak A.S., Stocker A.M., Chenn A., Gottardi C.J. Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J.Cell. Biol. 2009, 186:219-228.
25. Maher M.T., Mo R., Flozak A.S., Peled O.N., Gottardi C.J. Beta-catenin phosphorylated at serine 45 is spatially uncoupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling. PLoS One 2010, 5:e10184.
26. Mao W., Millar J.C., Wang W.H., Silverman S.M., Liu Y., Wordinger R.J., Rubin J.S., Pang I.H., Clark A.F. Existence of the canonical Wnt signaling pathway in the human trabecular meshwork. Invest Ophthalmol. Vis. Sci. 2012, 53(11):7043-7051.
27. McKee C.T., Wood J.A., Shah N.M., Fischer M.E., Reilly C.M., Murphy C.J., Russell P. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents. Biomaterials 2011, 32:2417-2423.
28. Minami I., Yamada K., Otsuji T.G., Yamamoto T., Shen Y., Otsuka S., Kadota S., Morone N., Barve M., Asai Y., Tenkova-Heuser T., Heuser J.E., Uesugi M., Aiba K., Nakatsuji N. Asmall molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell. Rep. 2012, 2:1448-1460.
29. Morgan J.T., Wood J.A., Walker N.J., Raghunathan V.K., Borjesson D.L., Murphy C.J., Russell P. Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells. J.Ocul. Pharmacol. Ther. 2014, 30:254-266.
30. Murphy K.C., Morgan J.T., Wood J.A., Sadeli A., Murphy C.J., Russell P. The formation of cortical actin arrays in human trabecular meshwork cells in response to cytoskeletal disruption. Exp. Cell. Res. 2014, 328(1):164-171.
31. Quigley H.A. Open-angle glaucoma. N.Engl. J. Med. 1993, 328:1097-1106.
32. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
33. Raghunathan V.K., Morgan J.T., Dreier B., Reilly C.M., Thomasy S.M., Wood J.A., Ly I., Tuyen B.C., Hughbanks M., Murphy C.J., Russell P. Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ. Invest Ophthalmol. Vis. Sci. 2013, 54:378-386.
34. Rohen J.W., Lutjen-Drecoll E., Flugel C., Meyer M., Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp. Eye Res. 1993, 56:683-692.
35. Saika S. TGFbeta pathobiology in the eye. Lab. Invest 2006, 86:106-115.
36. Satoh W., Matsuyama M., Takemura H., Aizawa S., Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis 2008, 46:92-103.
37. Shyam R., Shen X., Yue B.Y., Wentz-Hunter K.K. Wnt gene expression in human trabecular meshwork cells. Mol. Vis. 2010, 16:122-129.
38. Staal F.J., Noort Mv M., Strous G.J., Clevers H.C. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep. 2002, 3:63-68.
39. Verma U.N., Surabhi R.M., Schmaltieg A., Becerra C., Gaynor R.B. Small interfering RNAs directed against beta-catenin inhibit the invitro and invivo growth of colon cancer cells. Clin. Cancer Res. 2003, 9:1291-1300.
40. Vinckier A., Semenza G. Measuring elasticity of biological materials by atomic force microscopy. FEBS Lett. 1998, 430:12-16.
41. Wang W.H., McNatt L.G., Pang I.H., Millar J.C., Hellberg P.E., Hellberg M.H., Steely H.T., Rubin J.S., Fingert J.H., Sheffield V.C., Stone E.M., Clark A.F. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J.Clin. Invest 2008, 118:1056-1064.
42. Yu J., Virshup D.M. Updating the Wnt pathways. Biosci. Rep. 2014, 34(5). pii:e00142.
43. Zhang K.S., Zhou Q., Wang Y.F., Liang L.J. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells. Oncol. Rep. 2013, 30:1430-1438.